CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 13 enrolled
Drug / intervention
Efinaconazole 10% Topical Application Solution [JUBLIA] +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03110029
NCT03110029Phase 4Completed

Evaluating the Efficacy and Compatibility of Efinaconazole 10% Solution (Jublia) for the Treatment of Toenail Onychomycosis in Patients Wearing Toenail Polish Compared to Those Without Polish

University of Alabama at Birmingham·interventional·Posted Apr 12, 2017·Updated Jun 27, 2019

In Brief

A Phase 4 clinical trial evaluating Efinaconazole 10% Topical Application Solution [JUBLIA] and Application of Nail Polish for Onychomycosis of Toenail. Completed, enrolled 13 participants across 1 site.

Detailed Summary

This study will test how well efinaconazole solution (Jublia) works to treat toenail fungal infections in patients who wear polish compared to those who do not.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 12, 2017
Enrollment StartSep 1, 2015
Primary CompletionMay 1, 2017
Study CompletionJul 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 9.2 years ago

Interventions

Efinaconazole 10% Topical Application Solution [JUBLIA]drug

Topical efinaconazole 10% solution (Jublia)

Application of Nail Polishother

Application of Nail Polish